The Influence of Oral Cannabidiol on 24-h Ambulatory Blood Pressure and Arterial Stiffness in Untreated Hypertension: A Double-Blind, Placebo-Controlled, Cross-Over Pilot Study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Influence of Oral Cannabidiol on 24-h Ambulatory Blood Pressure and Arterial Stiffness in Untreated Hypertension: A Double-Blind, Placebo-Controlled, Cross-Over Pilot Study
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-06-09
DOI
10.1007/s12325-023-02560-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CBD supplementation reduces arterial blood pressure via modulation of the sympatho-chromaffin system: A substudy from the HYPER-H21-4 trial
- (2023) Marko Kumric et al. BIOMEDICINE & PHARMACOTHERAPY
- Role of Catestatin in the Cardiovascular System and Metabolic Disorders
- (2022) Ewa Zalewska et al. Frontiers in Cardiovascular Medicine
- Chronic Effects of Effective Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure and Vascular Outcomes in Treated and Untreated Hypertension (HYPER-H21-4): Study Protocol for a Randomized, Placebo-Controlled, and Crossover Study
- (2022) Marko Kumric et al. Journal of Personalized Medicine
- Serum Catestatin Levels Correlate with Ambulatory Blood Pressure and Indices of Arterial Stiffness in Patients with Primary Hypertension
- (2022) Marko Kumric et al. Biomolecules
- Why Multitarget Vasodilatory (Endo)cannabinoids Are Not Effective as Antihypertensive Compounds after Chronic Administration: Comparison of Their Effects on Systemic and Pulmonary Hypertension
- (2022) Patryk Remiszewski et al. Pharmaceuticals
- Cannabis is associated with blood pressure reduction in older adults – A 24-hours ambulatory blood pressure monitoring study
- (2021) Ran Abuhasira et al. European Journal of Internal Medicine
- A placebo‐controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans
- (2021) Caroline A. Arout et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Autonomic nervous system activity changes in patients with hypertension and overweight: role and therapeutic implications
- (2021) Paul Valensi Cardiovascular Diabetology
- The effects of acute and sustained cannabidiol dosing for seven days on the haemodynamics in healthy men: A randomised controlled trial
- (2020) Salahaden R. Sultan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism
- (2020) Patryk Remiszewski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabinoids as anticancer therapeutic agents
- (2020) Olga Kovalchuk et al. CELL CYCLE
- Comprehensive Evaluation of Rhythm Monitoring Strategies in Screening for Atrial Fibrillation
- (2020) Søren Zöga Diederichsen et al. CIRCULATION
- Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications
- (2020) Emilio Perucca et al. CNS DRUGS
- Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart
- (2020) Anna Pędzińska-Betiuk et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association
- (2019) Paul Muntner et al. HYPERTENSION
- Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy
- (2019) Angela K. Birnbaum et al. EPILEPSIA
- Validity Evaluation of the Fitbit Charge2 and the Garmin vivosmart HR+ in Free-Living Environments in an Older Adult Cohort
- (2019) Salvatore Tedesco et al. JMIR mHealth and uHealth
- Examination of a New Delivery Approach for Oral Cannabidiol in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Pharmacokinetics Study
- (2019) Alexander Patrician et al. ADVANCES IN THERAPY
- Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries
- (2019) Marta Baranowska-Kuczko et al. JOURNAL OF HYPERTENSION
- Antioxidative and Anti-Inflammatory Properties of Cannabidiol
- (2019) Sinemyiz Atalay et al. Antioxidants
- Cannabinoids, the Heart of the Matter
- (2018) Naghum Alfulaij et al. Journal of the American Heart Association
- A Systematic Review of the Complex Effects of Cannabinoids on Cerebral and Peripheral Circulation in Animal Models
- (2018) J. Sebastian Richter et al. Frontiers in Physiology
- Interaction Between Hypertension and Arterial Stiffness
- (2018) Michel E. Safar et al. HYPERTENSION
- Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life
- (2018) Yuichiro Yano et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sex difference in brain CB1 receptor availability in man
- (2018) Heikki Laurikainen et al. NEUROIMAGE
- Interactions between cannabidiol and commonly used antiepileptic drugs
- (2017) Tyler E. Gaston et al. EPILEPSIA
- lmerTest Package: Tests in Linear Mixed Effects Models
- (2017) Alexandra Kuznetsova et al. Journal of Statistical Software
- Fitness, Fatness, Physical Activity, and Autonomic Function in Midlife
- (2017) ANTTI M. KIVINIEMI et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol
- (2017) Salahaden R. Sultan et al. Frontiers in Pharmacology
- Cannabinoids and Cytochrome P450 Interactions
- (2016) Ondřej Zendulka et al. CURRENT DRUG METABOLISM
- Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide Pathway
- (2016) Malapaka Kiranmayi et al. HYPERTENSION
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1activation
- (2015) Christopher P. Stanley et al. CARDIOVASCULAR RESEARCH
- A Randomized Trial of Intensive versus Standard Blood-Pressure Control
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Cannabinoid modulation of alpha2adrenergic receptor function in rodent medial prefrontal cortex
- (2014) Alessandra M. Cathel et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
- (2013) Stephen M. Stout et al. DRUG METABOLISM REVIEWS
- Regulation of Vascular Tone and Pulse Wave Velocity in Human Muscular Conduit Arteries
- (2012) Henry Fok et al. HYPERTENSION
- Cannabinoid and GABA modulation of sympathetic nerve activity and blood pressure in the dorsal periaqueductal gray of the rat
- (2011) C. Dean AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Plasma catecholamine release-inhibitory peptide catestatin in patients with essential hypertension
- (2011) Lei Meng et al. Journal of Cardiovascular Medicine
- Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress
- (2011) Érica M. Granjeiro et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Morning Surge in Blood Pressure and Cardiovascular Risk
- (2010) Kazuomi Kario HYPERTENSION
- Diurnal blood pressure variation and sympathetic activity
- (2010) Guido Grassi et al. HYPERTENSION RESEARCH
- A new oscillometric method for pulse wave analysis: comparison with a common tonometric method
- (2010) S Wassertheurer et al. JOURNAL OF HUMAN HYPERTENSION
- Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials
- (2010) Paolo Verdecchia et al. JOURNAL OF HYPERTENSION
- Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors
- (2010) Felipe V Gomes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
- (2010) Charalambos Vlachopoulos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist
- (2009) MG Cascio et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search